P-LLY Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Zepbound (tirzepatide) as a potential treatment for adults with obesity or overweight and the timeline for additional regulatory submissions, future readouts, supply and commercialization of Zepbound, presentations, and other milestones relating to Zepbound and reflects Lilly's current belief and expectations
2 People with this condition may also be insulin resistant, meaning cells begin to not respond appropriately to insulin and take in less sugar as a result
Claims data reflect routine clinical practice rather than mandatory assessments at prespecified time points, which may have impacted the amount of data available for observation
It isnt clear if L-glutamine supplementation is safe during pregnancy or breastfeeding, so you may want to avoid L-glutamine supplements in these cases
Do not inject where the sk in has p its , is t hic k ened, or has l um ps
